坂東 裕子(バンドウ ヒロコ)

研究者情報全体を表示

論文

• 当科における男性医師の育児休業および育児休暇に関する現状と課題
  松尾知平; 西野ひかる; 濱岡武; 蒲原玲南; 佐藤璃子; 星葵; 上田文; 岡﨑舞; 橋本幸枝; 井口研子; 坂...
  日本内分泌外科学会雑誌　/42(1)/pp.S162-S162, 2025-04-25
• 221P Long-term outcomes of eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer: Results of the randomized JBCRG-22 study
  Yasojima H; Masuda N; BANDO Hiroko; Yamanaka H; Shige...
  ESMO open/10(4), 2025-05-14
• Patient-reported fatigue and general pain and the impact on health-related quality of life (HRQoL) in Japanese patients with advanced breast cancer (ABC) treated with palbociclib (PAL) + endocrine therapy (ET): Analysis from 6-month observational study (JBCRG-26)
  BANDO Hiroko; Oba Mari; Ueda Aya; Kaori Terata; Doi Miho...
  ESMO OPEN/10(4), 2025-05-14
• Overall efficacy and safety of olanzapine 5 mg added to triplet antiemetics for an anthracycline-containing regimen in patients with breast cancer: a phase 3, double-blind, randomised, placebo-controlled trial
  Saito Mitsue; Iihara Hirotoshi; Shimokawa Mototsugu; U...
  The Lancet. Oncology/26(7)/pp.960-970, 2025-07-01
  
  PubMed
• Health-related quality of life and physical activity collected via mobile application and wearable device in patients with HR +/HER2 - advanced breast cancer treated with palbociclib plus endocrine therapy or endocrine therapy alone: 6-month longitudinal study (JBCRG-26)
  Bando Hiroko; Ueda Aya; Terata Kaori; Doi Mihoko; Nag...
  Breast cancer (Tokyo, Japan), 2025-07-18
  
  PubMed
• リンパ節内リンパ管造影検査が頸部郭清後乳糜漏の漏出部位特定に有用であった甲状腺癌の１例
  佐藤 璃子; 岡﨑 舞; 渡邊 瑞穂; 白谷 理恵; 竹内 直人; 寺崎 梓; 澤 文; 市岡 恵...
  日本内分泌外科学会雑誌/41(4)/pp.317-321, 2024
• Distinct follicular T cell subsets regulate lymphoma progression and outcomes
  Abe Yoshiaki; Zenkoh Junko; Kanai Akinori; Ikeda Daisuke...
  Cancer cell/43(10), 2025-07-01
  
  PubMed
• A mixed-methods feasibility study to evaluate and assess the clinical utility of multidisciplinary patient-centered information in breast cancer care.
  Bando Hiroko; Utsunomiya Kazuki; Fujimoto Katsuhiko; S...
  JOURNAL OF CLINICAL ONCOLOGY/43(16_SUPPL:16_SUPPL)/pp.e13594-e13594, 2025-06-01
• Real-world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first- or second-line treatment for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer
  Yoshinami Tetsuhiro; Takano Yuko; Ozaki Yukinori; Kaji...
  BREAST CANCER, 2025-05-20
• Non-cancer risks among female breast cancer survivors: a matched cohort study in Japan
  Kawamura Chitose; Bhaskaran Krishnan; Konishi Takaaki; ...
  LANCET REGIONAL HEALTH-WESTERN PACIFIC/56, 2025-03
• Clinical Utility of Integrated Multidisciplinary Patient-Centered Information in Breast Cancer Care: A Mixed Methods Study
  Sugiyama Atsuko; Utsunomiya Kazuki; Fujimoto Katsuhiko...
  Journal of multidisciplinary healthcare/18/pp.1875-1893, 2025-04-01
  
  PubMed
• HLA class II-restricted T cell epitopes in public neoantigens of ESR1 and PIK3CA in breast cancer
  Ando Yukari; Miyadera Hiroko; Bando Hiroko; Hashimoto ...
  BMC cancer/25(1)/p.610, 2025-04-04
  
  PubMed
• Sentinel lymph node biopsy in clinical T3-4c breast cancer: A retrospective multicenter cohort study
  Sagara Y.; Kuba S.; Maeda S.; Yano H.; Sakai T.; Koj...
  ANNALS OF ONCOLOGY/35(2)/pp.S349-S349, 2024-09
• Tumor Immunoregulatory Mechanisms by Nonmetastatic Melanoma Protein B in Triple Negative Breast Cancer
  Kawanishi Kunio; Dangcao Thuylinh; Okita Yukari; Watan...
  CANCER SCIENCE/116(1:SI)/pp.664-664, 2025-01
• Exploration of therapeutic target molecules for triple negative breast cancer by spatial transcriptome analysis
  Shiratani Rie; Kawanishi Kunio; Hengphasatporn Kowit; ...
  CANCER SCIENCE/116(1:SI)/pp.472-472, 2025-01
• Efficacy and Safety of Mirogabalin Therapy for Paclitaxel-Induced Peripheral Neuropathy (MICHEL Study): A Pilot Study
  Sawa Aya; Bando Hiroko; Sato Riko; Matsuo Tomohei; Ok...
  Oncology/pp.1-12, 2025-02-03
  
  PubMed
• Spatially Resolved Single-Cell Transcriptomics of T Cells in Follicular Lymphoma Reveals Distinct Immune Ecosystems
  Abe Yoshiaki; Zenkoh Junko; Kanai Akinori; Ikeda Dais...
  BLOOD/144(1)/pp.741-742, 2024-11-05
• Single-cell survey reveals minor cell subsets in lymphoma microenvironment
  Abe Yoshiaki; Zenkoh Junko; Fujisawa Manabu; Miyoshi ...
  CANCER SCIENCE/115(1)/pp.352-352, 2024-03
• Exploration of public neoantigen in breast cancer that could be an HLA class II restricted T cell epitope
  Ando Yukari; Miyadera Hiroko; Hashimoto Sachie; Hara ...
  CANCER SCIENCE/115(1)/pp.834-834, 2024-03
• RWE（real world evidence）の創出とその意義
  坂東 裕子
  日本臨牀増刊号　乳癌学2024下/82(7)/pp.261-266, 2024-9-30
• Examining the association between patient-reported outcomes and physical activity metrics in patients with HR1/ HER2 advanced breast cancer treated with palbociclib plus endocrine therapy or endocrine therapy alone
  Oba Mari S.; Miyaji Tempei; Bando Hiroko; Ueda Aya; T...
  QUALITY OF LIFE RESEARCH/33(1)/pp.S40-S41, 2024-10
• 当院における甲状腺分化癌と良性症例の腫瘍径とサイログロブリン値の傾向
  蒲原 玲南; 井口 研子; 大谷 光; 柳瀬 友里菜; 渡邊 瑞穂; 佐藤 璃子; 松尾 知平; 上...
  第36回日本内分泌外科学会総会抄録集/41(180)/pp.S227-S227, 2024/4
• 当院における副甲状腺癌の術前診断と術後経過に関する検討
  松尾 知平; 井口 研子; 柳瀬 友里菜; 大谷 光; 渡邊 瑞穂; 蒲原 玲南; 佐藤 璃子; 上...
  第36回日本内分泌外科学会総会抄録集/41(180)/pp.S195-S195, 2024/4
• 腎移植患者で副甲状腺機能亢進症に対する手術過料を行った2例の検討
  柳瀬 友里菜; 佐藤 璃子; 井口 研子; 大谷 光; 渡邊 瑞穂; 蒲原 玲南; 松尾 知平; 上...
  第36回日本内分泌外科学会総会抄録集/41(180)/pp.S235-S235, 2024/4
• アベマシクリブ治療を受ける乳がん患者と医師のコミュニケーションに関するオンライン調査
  井関千裕; 鳥口尚子; 谷澤欣則; 関根信幸; 水野聖子; 大佐賀智; 坂東 裕子
  癌と化学療法/51(12)/pp.1227-1237, 2024-12
• さらに表示...